AAAAAA

   
Results: 1-9 |
Results: 9
THE 677C-T MUTATION IN THE METHYLENE-TETRAHYDROFOLATE REDUCTASE GENE IS NOT RELATED TO HYPERHOMOCYSTEINEMIA IN THROMBOTIC DISEASE
Authors: ANKRI A BONNEFONT JP CHADEFAUXVEKEMANS B MOSTEFA AK AUPETIT J COUTY MC MONTALESCOT G KAMOUN P THUILLIER L
Citation: A. Ankri et al., THE 677C-T MUTATION IN THE METHYLENE-TETRAHYDROFOLATE REDUCTASE GENE IS NOT RELATED TO HYPERHOMOCYSTEINEMIA IN THROMBOTIC DISEASE, Thrombosis and haemostasis, 1997, pp. 2160-2160
PREVALENCE OF MILD HYPERHOMOCYSTEINEMIA IN ARTERIAL AND VENOUS THROMBOSIS DISEASE ACCORDING TO GENDER
Authors: ANKRI A MONTALESCOT G CHADEFAUX B COUTY MC SOUNI F THOMAS D BINET JL
Citation: A. Ankri et al., PREVALENCE OF MILD HYPERHOMOCYSTEINEMIA IN ARTERIAL AND VENOUS THROMBOSIS DISEASE ACCORDING TO GENDER, Thrombosis and haemostasis, 1997, pp. 2167-2167
WHAT IS THE SIGNIFICANCE OF ANTIPHOSPHOLIPID ANTIBODIES (APL) IN HIV-INFECTED PATIENTS
Authors: ANKRI A KARMOCHKINE M COUTELLIER A COUTY MC HERSON S
Citation: A. Ankri et al., WHAT IS THE SIGNIFICANCE OF ANTIPHOSPHOLIPID ANTIBODIES (APL) IN HIV-INFECTED PATIENTS, Thrombosis and haemostasis, 1997, pp. 2207-2207
MILD HYPERHOMOCYSTEINEMIA IS A GRADUATE RISK FACTOR FOR ARTERIAL AND VENOUS THROMBOSIS DISEASE
Authors: ANKRI A MONTALESCOT G CHADEFAUX B BLACHER J COUTY MC KAMOUN P THOMAS D BINET JL
Citation: A. Ankri et al., MILD HYPERHOMOCYSTEINEMIA IS A GRADUATE RISK FACTOR FOR ARTERIAL AND VENOUS THROMBOSIS DISEASE, Blood, 90(10), 1997, pp. 667-667
DOES THE PREVALENT MUTATION 677-]T IN THE METHYLENE-TETRAHYDROFOLATE REDUCTASE GENE CONTRIBUTE TO HYPERHOMOCYSTEINEMIA RELATED TO VASCULAR-DISEASE
Authors: ANKRI A CHADEFAUXVEKEMANS B MOSTEFA AK AUPETIT J THUILLIER L COUTY MC MONTALESCOT G KAMOUN P BONNEFORT JP
Citation: A. Ankri et al., DOES THE PREVALENT MUTATION 677-]T IN THE METHYLENE-TETRAHYDROFOLATE REDUCTASE GENE CONTRIBUTE TO HYPERHOMOCYSTEINEMIA RELATED TO VASCULAR-DISEASE, Blood, 88(10), 1996, pp. 665-665
MILD HYPERHOMOCYSTEINEMIA IS A RISK FACTOR FOR ARTERIAL AND VENOUS THROMBOSIS
Authors: ANKRI A MONTALESCOT G CHADEFAUX B ANKRI J SOUNI F BELKASMI F COUTY MC BLACHET J THOMAS D BONET JL
Citation: A. Ankri et al., MILD HYPERHOMOCYSTEINEMIA IS A RISK FACTOR FOR ARTERIAL AND VENOUS THROMBOSIS, Blood, 86(10), 1995, pp. 3639-3639
TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) LYMPHOCYTES
Authors: ANKRI A MENTZ F CHEVRET S COUTY MC BINET JL
Citation: A. Ankri et al., TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) LYMPHOCYTES, Blood, 84(10), 1994, pp. 10000459-10000459
BETA-2-GLYCOPROTEIN-1 AND THROMBOTIC RISK IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
Authors: ANKRI A MAHOUN H COUTY MC REBOUL J LESTY C CAMBUSSE JP
Citation: A. Ankri et al., BETA-2-GLYCOPROTEIN-1 AND THROMBOTIC RISK IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES, Thrombosis and haemostasis, 69(6), 1993, pp. 598-598
COMPARISON OF 7 METHODS USING ELISA FOR THE DETECTION OF ANTICARDIOLIPIN OR ANTIPHOSPHOLIPID ANTIBODIES IN 28 PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME
Authors: ANKRI A MAHOUN H COUTY MC LESTY C CHATELIER G
Citation: A. Ankri et al., COMPARISON OF 7 METHODS USING ELISA FOR THE DETECTION OF ANTICARDIOLIPIN OR ANTIPHOSPHOLIPID ANTIBODIES IN 28 PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME, Thrombosis and haemostasis, 69(6), 1993, pp. 1033-1033
Risultati: 1-9 |